BACK MATTER / CONTACT
Editorial correspondence.
Spotted an error? Have a citation to add? Want to flag a trial we've missed? Here is how to reach the editors.
What we read
We read messages about three things, in priority order:
- Corrections. If you find a quantitative or citation error, please tell us. Cite the specific page, the specific sentence, and the source you think is correct. We will verify and update.
- Citation additions. If a relevant pivotal trial has published and we have not summarized it, please send the DOI and a one-sentence rationale.
- Editorial feedback. If a page is unclear, missing context, or reads like marketing rather than reporting, we want to hear that.
What we do not respond to: requests for medical advice; requests to recommend a vendor, telehealth provider, or compounding pharmacy; requests to remove a clinical fact because it is unflattering to a product; requests to add affiliate links.
How to reach us
Use the form below or send a plain-text email to editors@tirzepatidemedicine.com. We do not subscribe you to anything. We do not share your address. We do not retain messages beyond what is needed to reply.
For the form, the only required fields are a subject and a message. An email address is optional, but we cannot reply without one.
Disclaimer, repeated
This site is an independent editorial chronicle of publicly available clinical research on tirzepatide. It is not medical advice. If you are considering or taking tirzepatide, please consult a clinician familiar with your medical history. This site is not affiliated with any vendor, manufacturer, or pharmaceutical company, and does not sell or endorse any product.